DFS of patients receiving trastuzumab was higher than of those not receiving trastuzumab; however, the difference did not reach statistical significance ( Figure 2A ).
← all excerpts
Central Nervous System Failure in Korean Breast Cancer Patients with HER2-Enriched Subtype: Korean Radiation Oncology Group 16-15 Multicenter Retrospective Study.
1
—
—